Consequently, we conducted a comprehensive examination of the impact of FDX1 on various aspects of glioblastoma multiforme's (GBM) tumor microenvironment (TME), metabolic pathways, immune micro-environment, and drug responsiveness. The gene discussed is FDX1; the disease is neoplasm.